Annual EBIT
-$58.41 M
-$6.67 M-12.89%
December 31, 2023
Summary
- As of February 7, 2025, IMRX annual earnings before interest & taxes is -$58.41 million, with the most recent change of -$6.67 million (-12.89%) on December 31, 2023.
- During the last 3 years, IMRX annual EBIT has fallen by -$41.33 million (-241.95%).
- IMRX annual EBIT is now -693.86% below its all-time high of -$7.36 million, reached on December 31, 2019.
Performance
IMRX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$15.27 M
-$360.90 K-2.42%
September 30, 2024
Summary
- As of February 7, 2025, IMRX quarterly earnings before interest & taxes is -$15.27 million, with the most recent change of -$360.90 thousand (-2.42%) on September 30, 2024.
- Over the past year, IMRX quarterly EBIT has increased by +$51.50 thousand (+0.34%).
- IMRX quarterly EBIT is now -371.54% below its all-time high of -$3.24 million, reached on March 31, 2020.
Performance
IMRX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$74.20 M
-$1.35 M-1.85%
September 30, 2024
Summary
- As of February 7, 2025, IMRX TTM earnings before interest & taxes is -$74.20 million, with the most recent change of -$1.35 million (-1.85%) on September 30, 2024.
- Over the past year, IMRX TTM EBIT has dropped by -$2.76 million (-3.86%).
- IMRX TTM EBIT is now -2190.78% below its all-time high of -$3.24 million, reached on March 31, 2020.
Performance
IMRX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
IMRX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -12.9% | +0.3% | -3.9% |
| 3 y3 years | -241.9% | -9.2% | -43.4% |
| 5 y5 years | -693.9% | -9.2% | -43.4% |
IMRX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -72.4% | at low | -37.4% | +46.8% | -119.0% | at low |
| 5 y | 5-year | -693.9% | at low | -371.5% | +46.8% | -2190.8% | at low |
| alltime | all time | -693.9% | at low | -371.5% | +46.8% | -2190.8% | at low |
Immuneering EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$15.27 M(+2.4%) | -$74.20 M(+1.8%) |
| Jun 2024 | - | -$14.91 M(-2.7%) | -$72.86 M(+2.0%) |
| Mar 2024 | - | -$15.33 M(-46.6%) | -$71.45 M(+1.0%) |
| Dec 2023 | -$58.41 M(+12.9%) | -$28.69 M(+106.0%) | -$70.72 M(+26.2%) |
| Sep 2023 | - | -$13.93 M(+3.1%) | -$56.02 M(+1.3%) |
| Jun 2023 | - | -$13.51 M(-7.5%) | -$55.28 M(+3.5%) |
| Mar 2023 | - | -$14.60 M(+4.4%) | -$53.42 M(+3.2%) |
| Dec 2022 | -$51.75 M | -$13.99 M(+6.0%) | -$51.75 M(+5.9%) |
| Sep 2022 | - | -$13.19 M(+13.2%) | -$48.88 M(+10.5%) |
| Jun 2022 | - | -$11.65 M(-9.9%) | -$44.23 M(+9.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$12.93 M(+16.3%) | -$40.58 M(+19.7%) |
| Dec 2021 | -$33.89 M(+98.4%) | -$11.12 M(+30.1%) | -$33.89 M(+18.5%) |
| Sep 2021 | - | -$8.54 M(+6.9%) | -$28.61 M(+16.9%) |
| Jun 2021 | - | -$7.99 M(+28.1%) | -$24.46 M(+21.8%) |
| Mar 2021 | - | -$6.24 M(+6.8%) | -$20.08 M(+17.5%) |
| Dec 2020 | -$17.08 M(+132.2%) | -$5.84 M(+32.6%) | -$17.08 M(+51.9%) |
| Sep 2020 | - | -$4.40 M(+22.0%) | -$11.25 M(+64.3%) |
| Jun 2020 | - | -$3.61 M(+11.3%) | -$6.85 M(+111.3%) |
| Mar 2020 | - | -$3.24 M | -$3.24 M |
| Dec 2019 | -$7.36 M | - | - |
FAQ
- What is Immuneering annual earnings before interest & taxes?
- What is the all time high annual EBIT for Immuneering?
- What is Immuneering annual EBIT year-on-year change?
- What is Immuneering quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Immuneering?
- What is Immuneering quarterly EBIT year-on-year change?
- What is Immuneering TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Immuneering?
- What is Immuneering TTM EBIT year-on-year change?
What is Immuneering annual earnings before interest & taxes?
The current annual EBIT of IMRX is -$58.41 M
What is the all time high annual EBIT for Immuneering?
Immuneering all-time high annual earnings before interest & taxes is -$7.36 M
What is Immuneering annual EBIT year-on-year change?
Over the past year, IMRX annual earnings before interest & taxes has changed by -$6.67 M (-12.89%)
What is Immuneering quarterly earnings before interest & taxes?
The current quarterly EBIT of IMRX is -$15.27 M
What is the all time high quarterly EBIT for Immuneering?
Immuneering all-time high quarterly earnings before interest & taxes is -$3.24 M
What is Immuneering quarterly EBIT year-on-year change?
Over the past year, IMRX quarterly earnings before interest & taxes has changed by +$51.50 K (+0.34%)
What is Immuneering TTM earnings before interest & taxes?
The current TTM EBIT of IMRX is -$74.20 M
What is the all time high TTM EBIT for Immuneering?
Immuneering all-time high TTM earnings before interest & taxes is -$3.24 M
What is Immuneering TTM EBIT year-on-year change?
Over the past year, IMRX TTM earnings before interest & taxes has changed by -$2.76 M (-3.86%)